References
- Oesterling JE. Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate. J Urol 1991;145:907–23.
- Partin AW, Oesterling JE. The clinical usefulness of prostate specific antigen: update 1994. J Urol 1994;152:1358–68.
- Polascik TJ, Oesterling JE, Partin AW. Prostate specific antigen: a decade of discovery—what we have learned and where we are going. J Urol 1999;162:293–306.
- Hernandez J, Thompson IM. Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 2004;101:894–904.
- Brett TD. An analysis of digital rectal examination and serum-prostate-specific antigen in the early detection of prostate cancer in general practice. Fam Pract 1998;15: 529–33.
- Feneley MR, Brewster S. Opportunities and outcomes in early prostate cancer: a commentary on policy, pa-tient perspectives, trials and strategies. BJU hit 2003;91: 177–8.
- Weller D, May F, Rowett D, Esterman A, Pinnock C, Nicholson S, et al. Promoting better use of the PSA test in general practice: randomized controlled trial of educational strategies based on outreach visits and mailout. Fam Pract 2003;20:655–61.
- Iversen P, Rasmussen F, Mogensen P, Lundbeck F, Poulsen J, Roosen JU, et al. Prostatacancer—Klaringsrapport fra Dansk Uro-Onkologisk Udvalg 1998. Ugeskr Laeger 1999;Klaringsrapport No. 4.
- Eddy B, Kastner C, Miller P, Rané A. Are G.P.s referring efficiently for prostate cancer? A primary care audit. BJU Int 2002;90 (Suppl 1):44.
- Fowler FJ Jr, Bin L, Collins MM, Roberts RG, Oesterling JE, Wasson JH, et al. Prostate cancer screening and beliefs about treatment efficacy: a national survey of primary care physicians and urologists. Am J Med 1998;104: 526–32.
- Ekman P, Adolfsson J, Grönberg H. The natural history of prostate cancer. hi: Kaisary A, Murphy GP, Denis L, Griffiths K, editors. Textbook of prostate cancer. Pathology, diagnosis and treatment. London: Martin Dunitz; 2000. p. 1–16.
- Det Danske Rd for Prostatsygdomme. Available from: www.ddrp.dk
- Sorum PC, Shim J, Chasseigne G, Bonnin-Scaon S, Cogneau J, Mullet E. Why do primary care physicians in the United States and France order prostate-specific antigen tests for asymptomatic patients? Med Decis Making 2003; 23:301–13.
- Tudiver F, Herbert C, Goel V. Why don't family physicians follow clinical practice guidelines for cancer screening? Family Physician Study Group, Sociobehavioral Cancer Research Network, National Cancer Institute of Canada. CMAJ 1998;159:797–8.
- Luboldt HJ, Fornara P, Weissbach L, Wirth M, Lorenz W, Rubben H. Systematic development of a guideline for early detection of prostate cancer: the German way in the evidence gap. Eur Urol 2004;46:725–30.
- Harris R, Lohr KN. Screening for prostate cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:917–29.